David Murdoch

7.4k total citations · 1 hit paper
36 papers, 4.2k citations indexed

About

David Murdoch is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Murdoch has authored 36 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 16 papers in Epidemiology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Murdoch's work include Infective Endocarditis Diagnosis and Management (12 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Streptococcal Infections and Treatments (9 papers). David Murdoch is often cited by papers focused on Infective Endocarditis Diagnosis and Management (12 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Streptococcal Infections and Treatments (9 papers). David Murdoch collaborates with scholars based in New Zealand, United Kingdom and United States. David Murdoch's co-authors include Donna McTavish, John J.V. McMurray, Andrew Davie, Lynda Blue, Mark C. Petrie, Theresa A. McDonagh, Ian Ford, Vance G. Fowler, L. Barth Reller and Caroline Morrison and has published in prestigious journals such as JAMA, Circulation and Annals of Internal Medicine.

In The Last Decade

David Murdoch

36 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century

2009 1.5k citations David Murdoch Archives of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Murdoch New Zealand	26	2.3k	1.7k	1.5k	1.1k	828	36	4.2k
Elías Abrutyn United States	39	4.1k 1.8×	1.9k 1.2×	580 0.4×	1.2k 1.1×	684 0.8×	91	5.6k
Stefano Bassetti Switzerland	36	1.1k 0.5×	1.9k 1.1×	1.8k 1.3×	408 0.4×	786 0.9×	159	5.6k
Jeremy G. Wheeler United Kingdom	25	1.6k 0.7×	977 0.6×	850 0.6×	715 0.6×	816 1.0×	32	4.8k
David R. Murdoch New Zealand	43	2.7k 1.1×	1.4k 0.9×	1.4k 0.9×	1.1k 0.9×	371 0.4×	179	7.0k
Imad M. Tleyjeh United States	42	4.0k 1.7×	3.0k 1.8×	1.4k 1.0×	1.7k 1.5×	1.4k 1.6×	113	6.9k
N. Deborah Friedman Australia	28	2.0k 0.8×	1.1k 0.7×	309 0.2×	539 0.5×	1.3k 1.5×	99	4.8k
B. Régnier France	42	2.9k 1.2×	1.7k 1.0×	379 0.3×	894 0.8×	871 1.1×	142	5.9k
Michael J. Richards Australia	37	2.2k 0.9×	1.6k 1.0×	339 0.2×	490 0.4×	980 1.2×	144	6.1k
William E. Sanders United States	40	1.3k 0.6×	662 0.4×	1.9k 1.3×	298 0.3×	665 0.8×	133	6.6k
Eugene Athan Australia	33	2.0k 0.8×	1.6k 1.0×	307 0.2×	567 0.5×	599 0.7×	141	3.4k

Countries citing papers authored by David Murdoch

Since Specialization

Citations

This map shows the geographic impact of David Murdoch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Murdoch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Murdoch more than expected).

Fields of papers citing papers by David Murdoch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Murdoch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Murdoch. The network helps show where David Murdoch may publish in the future.

Co-authorship network of co-authors of David Murdoch

This figure shows the co-authorship network connecting the top 25 collaborators of David Murdoch. A scholar is included among the top collaborators of David Murdoch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Murdoch. David Murdoch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pericàs, Juan M., Jaume Llopis, Eugene Athan, et al.. (2021). Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs. Journal of the American College of Cardiology. 77(5). 544–555. 36 indexed citations

Bloomfield, Gerald S., Prateeti Khazanie, Alison Morris, et al.. (2014). HIV and Noncommunicable Cardiovascular and Pulmonary Diseases in Low- and Middle-Income Countries in the ART Era. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(Supplement 1). S40–S53. 92 indexed citations

Murdoch, David, et al.. (2012). Global Trends in Infective Endocarditis Epidemiology. Current Infectious Disease Reports. 14(4). 367–372. 59 indexed citations

Kiefer, Todd L., Lawrence Park, Christophe Tribouilloy, et al.. (2011). Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure. JAMA. 306(20). 2239–47. 145 indexed citations

Reynolds, Rebecca M., Brian R. Walker, Sally Haw, et al.. (2010). Low serum cortisol predicts early death after acute myocardial infarction. Critical Care Medicine. 38(3). 973–975. 22 indexed citations

Murdoch, David. (2009). Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century. Archives of Internal Medicine. 169(5). 463–463. 1541 indexed citations breakdown →

Lainchbury, John G., et al.. (2009). Outpatient intravenous treatment for infective endocarditis: Safety, effectiveness and one-year outcomes. Journal of Infection. 59(6). 387–393. 44 indexed citations

Huggan, Paul, David Murdoch, Kate Gallagher, & Stephen T. Chambers. (2008). Concomitant Staphylococcus aureus bacteriuria is associated with poor clinical outcome in adults with S. aureus bacteraemia. Journal of Hospital Infection. 69(4). 345–349. 34 indexed citations

Zimmerman, Mark, David Murdoch, Patrick J. Rozmajzl, et al.. (2008). Murine Typhus and Febrile Illness, Nepal. Emerging infectious diseases. 14(10). 1656–1659. 27 indexed citations

10.

Seed, Alison, Roy S. Gardner, John J.V. McMurray, et al.. (2007). Neurohumoral Effects of the New Orally Active Renin Inhibitor, Aliskiren, in Chronic Heart Failure. European Journal of Heart Failure. 9(11). 1120–1127. 48 indexed citations

11.

Woods, Christopher W., David Murdoch, Mark Zimmerman, et al.. (2006). Emergence of Salmonella enterica serotype Paratyphi A as a major cause of enteric fever in Kathmandu, Nepal. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100(11). 1063–1067. 71 indexed citations

12.

Everts, Richard J., Stephen T. Chambers, David Murdoch, Alastair G. Rothwell, & John McKie. (2004). Successful antimicrobial therapy and implant retention for streptococcal infection of prosthetic joints. ANZ Journal of Surgery. 74(4). 210–214. 34 indexed citations

13.

Anderson, Deverick J., David Murdoch, Daniel J. Sexton, et al.. (2004). Risk Factors for Infective Endocarditis in Patients with Enterococcal Bacteremia: A Case-Control Study. Infection. 32(2). 72–77. 58 indexed citations

14.

Price, Richard D. & David Murdoch. (2001). Case Report: Perniosis (Chilblains) of the Thigh: Report of Five Cases, Including Four Following River Crossings. High Altitude Medicine & Biology. 2(4). 535–538. 21 indexed citations

15.

Murdoch, David, S. A. Roberts, Vance G. Fowler, et al.. (2001). Infection of Orthopedic Prostheses after Staphylococcus aureus Bacteremia. Clinical Infectious Diseases. 32(4). 647–649. 188 indexed citations

16.

Blue, Lynda, Eva Lang, John J.V. McMurray, et al.. (2001). Randomised controlled trial of specialist nurse intervention in heart failure. BMJ. 323(7315). 715–718. 444 indexed citations

17.

Murdoch, David, Theresa A. McDonagh, John Byrne, et al.. (1999). Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. American Heart Journal. 138(6). 1126–1132. 182 indexed citations

18.

Murdoch, David, Michael P. Love, Sue Robb, et al.. (1998). Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979–1992. European Heart Journal. 19(12). 1829–1835. 74 indexed citations

19.

Jamieson, Andrew R., David Murdoch, John A. Kennedy, & John Connell. (1995). Left ventricular mass in hereditary human hypertension: glucocorticoid-suppressible hyperaldosteronism. Journal of Hypertension. 13(5). 551–556. 4 indexed citations

20.

Murdoch, David & Donna McTavish. (1991). Roxatidine Acetate. Drugs. 42(2). 240–260. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact